These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
738 related items for PubMed ID: 28380198
1. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes. Lobato GR, Lobato MR, Thomé FS, Veronese FV. Braz J Med Biol Res; 2017 Mar 30; 50(5):e6106. PubMed ID: 28380198 [Abstract] [Full Text] [Related]
2. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure. Jungbauer CG, Uecer E, Stadler S, Birner C, Buchner S, Maier LS, Luchner A. Nephrology (Carlton); 2016 Jun 30; 21(6):490-8. PubMed ID: 26422793 [Abstract] [Full Text] [Related]
6. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP, Holt SG. Nephrol Dial Transplant; 2013 Jun 30; 28(6):1569-79. PubMed ID: 23328709 [Abstract] [Full Text] [Related]
7. The Associations of Blood Kidney Injury Molecule-1 and Neutrophil Gelatinase-Associated Lipocalin with Progression from CKD to ESRD. Alderson HV, Ritchie JP, Pagano S, Middleton RJ, Pruijm M, Vuilleumier N, Kalra PA. Clin J Am Soc Nephrol; 2016 Dec 07; 11(12):2141-2149. PubMed ID: 27852662 [Abstract] [Full Text] [Related]
12. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF. Nephrol Dial Transplant; 2011 Nov 07; 26(11):3581-8. PubMed ID: 21467131 [Abstract] [Full Text] [Related]
15. Evaluation of urinary neutrophil gelatinase-associated lipocalin and urinary kidney injury molecule-1 as biomarkers of renal function in cancer patients treated with cisplatin. Ghadrdan E, Ebrahimpour S, Sadighi S, Chaibakhsh S, Jahangard-Rafsanjani Z. J Oncol Pharm Pract; 2020 Oct 07; 26(7):1643-1649. PubMed ID: 32046578 [Abstract] [Full Text] [Related]
17. Clinical Significance of Urinary Biomarkers in Patients With Primary Focal Segmental Glomerulosclerosis. Zhang Q, Jiang C, Tang T, Wang H, Xia Y, Shao Q, Zhang M. Am J Med Sci; 2018 Apr 07; 355(4):314-321. PubMed ID: 29661344 [Abstract] [Full Text] [Related]
19. Urinary biomarkers in the early detection and follow-up of tubular injury in childhood urolithiasis. Taşdemir M, Fuçucuoğlu D, Küçük SH, Erol M, Yiğit Ö, Bilge I. Clin Exp Nephrol; 2018 Feb 07; 22(1):133-141. PubMed ID: 28653226 [Abstract] [Full Text] [Related]
20. Urine NGAL and KIM-1: tubular injury markers in acute lymphoblastic leukemia survivors. Latoch E, Konończuk K, Taranta-Janusz K, Muszyńska-Rosłan K, Szymczak E, Wasilewska A, Krawczuk-Rybak M. Cancer Chemother Pharmacol; 2020 Dec 07; 86(6):741-749. PubMed ID: 33052454 [Abstract] [Full Text] [Related] Page: [Next] [New Search]